Results 11 to 20 of about 993,013 (333)

Human Hepatocellular Carcinoma (HCC) [PDF]

open access: yesCancers, 2020
Hepatocellular carcinoma (HCC) is the fifth most common cancer and accounts for 8 [...]
Luigi Buonaguro
openaire   +3 more sources

A Curious Case of Vanishing Hepatocellular Carcinoma (HCC). [PDF]

open access: yesCureus, 2023
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related mortality worldwide. Spontaneous regression of HCC is rare with few documented cases in literature. The mechanism of this phenomenon is unknown, but tumor hypoxia and systemic inflammatory response have been suggested as possible etiologies.
Kwei-Nsoro R   +4 more
europepmc   +3 more sources

Employing LI-RADS on dynamic MRI scans for distinguishing hepatocellular carcinoma from other hepatic focal lesions in high risk patients [PDF]

open access: yesAin Shams Medical Journal, 2023
ABackground: LI-RADS (Liver Imaging Reporting and Data System) provide standardization for screening high risk patients for hepatocellular carcinoma (HCC). Moreover, it aids in treatment response assessment. HCC is special among different malignancies in
heba ellaban, Rasha Aly, Sameh Abokoura
doaj   +2 more sources

Ciclopirox Olamine Induces Proliferation Inhibition and Protective Autophagy in Hepatocellular Carcinoma

open access: yesPharmaceuticals, 2023
Hepatocellular carcinoma is one of the most common fatal malignancies worldwide. Thus far, the hepatocellular carcinoma prognosis has been bleak due to deficiencies in the identification and diagnosis of early hepatocellular carcinoma. Ciclopirox olamine
Xinyan Wan   +8 more
doaj   +1 more source

Research Progress of Androgen/Androgen Receptor Signaling Pathway in Hepatocellular Carcinoma

open access: yesZhongliu Fangzhi Yanjiu, 2023
Hepatocellular carcinoma (HCC) is a kind of primary liver cancer with a high mortality rate. In China, the incidence ratio in males to females with HCC is 2:1–5:1.
WANG Ruihua   +4 more
doaj   +1 more source

Epigenetic Mechanisms Involved in HCV-Induced Hepatocellular Carcinoma (HCC)

open access: yesFrontiers in Oncology, 2021
Hepatocellular carcinoma (HCC), is the third leading cause of cancer-related deaths, which is largely caused by virus infection. About 80% of the virus-infected people develop a chronic infection that eventually leads to liver cirrhosis and ...
Pin Zhao, Samiullah Malik, Shao-Jun Xing
semanticscholar   +1 more source

Loss of the orphan nuclear receptor SHP is more pronounced in fibrolamellar carcinoma than in typical hepatocellular carcinoma. [PDF]

open access: yesPLoS ONE, 2012
Hepatocellular carcinoma (HCC) remains a major problem in oncology. The molecular mechanisms which underlie its pathogenesis are poorly understood. Recently the Small Heterodimer Partner (SHP), an orphan nuclear receptor, was suggested to be involved as ...
Ewa Wilczek   +7 more
doaj   +1 more source

Hepatocellular Carcinoma: The Role of MicroRNAs

open access: yesBiomolecules, 2022
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related deaths worldwide. HCC is diagnosed in its advanced stage when limited treatment options are available.
Sharad Khare   +3 more
doaj   +1 more source

Assessment of Serum Aldo-Keto Reductase Family 1 Member B10 for Early Diagnosis of Hepatocellular Carcinoma Patients in Suez Canal University Hospital, Egypt ‎ [PDF]

open access: yesAfro-Egyptian Journal of Infectious and Endemic Diseases, 2023
Background and study aim: Hepatocellular carcinoma is a challenging malignancy of global importance as it is considered the 2nd cause of mortality worldwide.
Mariam Makram   +3 more
doaj   +1 more source

Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification

open access: yesAdvances in Cancer Research, 2020
Hepatocellular carcinoma (HCC), the primary malignancy of hepatocytes, is a diagnosis with bleak outcome. According to National Cancer Institute’s SEER database, the average five-year survival rate of HCC patients in the US is 19.6% but can be as low as ...
Saranya Chidambaranathan-Reghupaty   +2 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy